Related Experiment Videos
Influence of teniposide on platelet functions in vitro
P Kubisz1, F Seghier, M Dobrotorá
1Division of Hematology, University Hospital, Martin, Slovakia.
Thrombosis Research
|January 15, 1995
Summary
Teniposide inhibits collagen-induced platelet aggregation and clot retraction but does not affect ADP-induced aggregation or platelet adhesion. This study investigates teniposide
Area of Science:
- Biochemistry
- Hematology
- Pharmacology
Background:
- Platelet aggregation plays a crucial role in hemostasis and thrombosis.
- Understanding the effects of therapeutic agents on platelet function is vital for clinical applications.
- Teniposide is an established chemotherapeutic agent with potential interactions with cellular processes.
Purpose of the Study:
- To investigate the impact of teniposide on various aspects of platelet function.
- To determine teniposide's effect on platelet aggregation, adhesion, and clot retraction.
Main Methods:
- Platelet-rich plasma was treated with teniposide.
- Platelet aggregation was induced by collagen and adenosine diphosphate (ADP).
- Platelet adhesion to glass, platelet factor 3 availability, clot retraction, and coagulation factors were assessed.
Main Results:
- Teniposide reduced collagen-induced platelet aggregation but not ADP-induced aggregation.
- Platelet factor 3 availability was decreased, and reptilase-induced clot retraction was reduced.
- Teniposide did not affect platelet adhesion to glass or coagulation factors.
Conclusions:
- Teniposide exhibits inhibitory effects on specific platelet functions, notably collagen-induced aggregation and clot retraction.
- The drug's impact on platelet factor 3 availability warrants further investigation.
- Teniposide does not appear to interfere with platelet adhesion or the general coagulation cascade.